Cargando…
Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP)
BACKGROUND: Community-acquired pneumonia (CAP) is a significant public health concern and a leading cause of hospitalization and inpatient antimicrobial use in the USA. However, determining the etiologic pathogen is challenging because traditional culture methods are slow and insensitive, leading to...
Autores principales: | Deshpande, Abhishek, Walker, Ramara, Schulte, Rebecca, Pallotta, Andrea M., Tereshchenko, Larisa G., Hu, Bo, Kadri, Sameer S., Klompas, Michael, Rothberg, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505312/ https://www.ncbi.nlm.nih.gov/pubmed/37716990 http://dx.doi.org/10.1186/s13063-023-07615-3 |
Ejemplares similares
-
2603. Acceptance of Pharmacist-Led Stewardship Recommendations for Patients with Community-Acquired Pneumonia
por: Walker, Ramara E, et al.
Publicado: (2023) -
1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020) -
879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022) -
Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021) -
2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
por: Bartley, Patricia, et al.
Publicado: (2019)